FIELD: medicine. SUBSTANCE: desired product has common formula C20H32O10N2Ca , and melting point 208-211 C. Ketopantolactone is used as reagent 1, calcium salt of γ-aminobutyric acid being used as reagent 2. Their interaction is carried out in alcohol medium by boiling. Yield of desired product is 83-85 EFFECT: improves quality of desired product. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
NOOTROPIC PREPARATION | 2001 |
|
RU2177783C1 |
SEDATIVE AND MUSCLE RELAXANT ACTION DRUG | 2019 |
|
RU2719376C1 |
BROMIDE OF 2-AMINO-(1-ADAMANTYLCARBONYLMETHYL)-1-(2-DIETHYLAMINOETHYL)-1-METHYLBENZIMIDAZOLIUM DISPLAYING PSYCHOSTIMULATING ANTICATALEPTIC ACTIVITY | 0 |
|
SU1108737A1 |
METHOD FOR SLEEP NORMALIZATION | 2002 |
|
RU2218933C2 |
COMBINED PREPARATION POSSESSING SEDATIVE, SPASMOLYTIC AND ANTI-ALLERGIC EFFECT | 2004 |
|
RU2295968C2 |
10-BENZYL-2-HYDROXY-4-OXO-4H-PYRIMIDO-[1,2-A]-BENZIMIDAZOLE SHOWING NEUROLEPTIC, ANTICONVULSANT, ANTIHYPOXIC, ANALGETIC AND ANTINOCICEPTIC ACTIVITIES | 1993 |
|
RU2042679C1 |
BROMIDE OF 2-AMINO-(1-ADAMANTYLCARBONYLMETHYL)-1-(BETA-MORPHOLINOETHYL)-BENZIMIDAZOLIUM DISPLAYING CAPACITY TO PROLONG ACTION OF BARBITURATES | 0 |
|
SU1053468A1 |
GENERAL ANESTHETIC BASED ON 3-AMINOMETHYLENINDOLINON-2 | 2006 |
|
RU2326113C2 |
PHARMACEOTICAL COMPOSITION POSSESSING SEDATIVE ANXIOLYTIC AND NOOTROPIC ACTION | 2009 |
|
RU2405551C1 |
MEANS FOR TREATMENT AND PREVENTION OF SLEEP DISORDERS | 2014 |
|
RU2566713C1 |
Authors
Dates
1995-10-10—Published
1993-06-30—Filed